The survival of advanced epithelia ovarian cancer patients who received laparoscopic primary or interval debulking surgery can be independently predicted by neutrophil to lymphocyte ratio.xlsx

<i>Neutrophil to lymphocyte ratio still could be used to predict the survival of </i><i>a</i>dvanced epithelia ovarian cancer patients who received <i>laparoscopic primary or interval debulking surgery. </i><i>In a word, </i><em>laparoscopic primary or interval debulking surgery </em><i></i><i>should be an available option for selected advanced patients in consideration of the facts that the two approaches for them didn’t change their outcomes and were safe for patients.</i>